Evommune, Inc. (EVMN) Return on equity
Evommune, Inc. (EVMN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-33.5%FY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -33.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More EVMN financial trends
EVMN RevenueEVMN Net incomeEVMN Net marginEVMN Gross profitEVMN Gross marginEVMN Operating incomeEVMN Operating marginEVMN Operating cash flowEVMN Free cash flowEVMN Capital expendituresEVMN Stock buybacksEVMN Dividends paidEVMN Total assetsEVMN Total liabilitiesEVMN Shareholders’ equityEVMN overview →